sb.scorecardresearch
Advertisement

Published 17:23 IST, March 1st 2024

Suven Pharma surges 13% on merger announcement with Cohance Lifesciences

The merger enhances Suven's position in the high-growth CDMO segment, providing multiple engines of growth through Pharma CDMO, Spec Chem CDMO, and API+.

Reported by: Business Desk
Follow: Google News Icon
  • share
Suven Pharma Cohance Lifesciences merger
Suven Pharma Cohance Lifesciences merger | Image: Republic
Advertisement

11:43 IST, March 1st 2024